PATENT CLAIM ANALYSIS

Application Number: 15762580
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "453000"]

Abstract:
The PKC activator bryostatin-1 and its analogs increase the survival of dermal fibroblast cells. Bryostatin and picolog, a synthetic analog, are used as candidate therapeutic agents for improving the appearance of aging skin, reducing scar tissue formation, and improving the acceptance of a clinical skin grafts.

Claim (Index 10):
The method of  claim 1 , wherein the one or more signs of aging is chosen from age spots, wrinkle, stretch marks, increased skin transparency, acne, dry skin, and loss of elasticity.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 90.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13817040', '14818576', '13178843', '14686711', '13561770']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7631587928820769
- 35 USC 102 Novelty (BERT): 0.5281939272872034
- Combined Prediction Score: 0.7396623063225896
- Mean Citation Score: 274.59551
- Max Citation Score: 291.85806
- Similarity Product: 145.55170867795232

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test